Issue 5/2014

Diffuse large B-cell lymphoma: The history, current view and new perspectives (491 — 504)

P. FLODR, P. LATALOVA, M. TICHY, Z. KUBOVA, T. PAPAJIK, M. SVACHOVA, K. VRZALIKOVA, L. RADOVA, M. JAROSOVA, P. MURRAY

DOI: 10.4149/neo_2014_062

Surface markers of hepatocellular cancer stem cells and their clinical potential (505 — 513)

D. FENG, N. WANG, J. HU, W. LI

DOI: 10.4149/neo_2014_061

SKLB-287, a novel oral multikinase inhibitor of EGFR and VEGFR2, exhibits potent antitumor activity in LoVo colorectal tumor model (514 — 522)

X. CHEN, Y. LIU, H.-W. YANG, S. ZHOU, C. CHENG, M.-W. ZHENG, L. ZHONG, X.-Y. FU, Y.-L. PAN, S. MA, Y. TANG, Y.-Z. CHEN, L.-L. LI, S.-Y. YANG

DOI: 10.4149/neo_2014_063

RNA interference-mediated knockdown of brain-derived neurotrophic factor (BDNF) promotes cell cycle arrest and apoptosis in B-cell lymphoma cells (523 — 532)

D. XIA, W. LI, L. ZHANG, H. QIAN, S. YAO, X. QI

DOI: 10.4149/neo_2014_064

Far upstream element-binding protein 1(FUBP1) expression differs between human colorectal cancer and non-cancerous tissue (533 — 540)

M. Y. JIA, Y. J. WANG

DOI: 10.4149/neo_2014_065

Fusion of human bone hemopoietic stem cell with esophageal carcinoma cells didn’t generate esophageal cancer stem cell (540 — 545)

H. FAN, S. LU

DOI: 10.4149/neo_2014_066

The decreased expression of protease-activated receptor 4 in esophageal squamous carcinoma (546 — 552)

S. LEE, P. JIANG, W. WANG, W. FENG, G. YU

DOI: 10.4149/neo_2014_067

Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells (553 — 565)

A. BREIER, J. STETKA, V. BOHACOVA, D. MACEJOVA, J. BRTKO, Z. SULOVA

DOI: 10.4149/neo_2014_068

Expression of serine and glycine-related enzymes in phyllodes tumor (566 — 578)

J. E. KWON, D. H. KIM, W.-H. JUNG, J. S. KOO

DOI: 10.4149/neo_2014_069

Serum high mobility group box protein 1 as a clinical marker for ovarian cancer (579 — 584)

Y. LI, J. TIAN, X. FU, Y. CHEN, W. ZHANG, H. YAO, Q. HAO

DOI: 10.4149/neo_2014_070

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia (585 — 592)

F. VRBACKY, J. NEKVINDOVA, V. REZACOVA, M. SIMKOVIC, M. MOTYCKOVA, D. BELADA, U. PAINULY, Z. JIRUCHOVA, J. MALY, J.  KREJSEK, P. ZAK, M. CERVINKA, L. SMOLEJ

DOI: 10.4149/neo_2014_071

A myeloablative conditioning regimen with fludarabine demonstrates good results in UCBT for 30 pediatric patients with hematologic malignancies, especially acute lymphoblastic leukemia (593 — 600)

J. TONG, Z. SUN, H. LIU, L. GENG, K. DING, X. WANG, C. ZHENG, B. TANG, X. ZHU, W. YAO, K. SONG, X. LIU

DOI: 10.4149/neo_2014_073

Surgical management of breast cancer liver metastases (601 — 606)

M. SABOL, R. DONAT, P. CHVALNY, D. DYTTERT, J. PALAJ, S. DURDIK

DOI: 10.4149/neo_2014_074

Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis (607 — 616)

Y. H. LEE, G. G. SONG

DOI: 10.4149/neo_2014_077

Constitutive 53BP1/γH2AX foci are increased in cells of ALL patients dependent on BCR-ABL and TEL-AML1 preleukemic gene fusions (617 — 625)

A. SOMSEDIKOVA, E. MARKOVA, A. KOLENOVA, J. PUSKACOVA, M. KUBES, I. BELYAEV

DOI: 10.4149/neo_2014_076